Skip to main content

Services of MTRC

08
Apr 2024

MTRC launched Knowledge Zone with brief overviews of the market access landscape and challenges for individual types of medical technologies in Europe

Market access is a rapidly changing field and the landscape varies for different types of medical technologies. To provide an additional, easy-to-access source of high-level information about key themes in the market access landscape and challenges for individual types of medical technologies, MTRC launched a dedicated Knowledge Zone on the website. Currently, the Knowledge Zone includes information about procedure coding, payment mechanisms, policy considerations, HTA, and future challenges for market access for 12 types of medical technologies. In the coming weeks, the Zone will expand 40 key technology groups
26
Feb 2024

Watch new short videos on the MTRC YouTube channel

MTRC released several short (2-4 minutes) educational videos on its YouTube channel: “Three common market access barriers for medical technologies”, “Reimbursement models and incentives for healthcare providers”, “How to spot a well-functioning DRG system?” and “Market access challenges for different types of medical technologies”. Videos can be of interest to an audience of both market access professionals and those new to the field of reimbursement, funding, HTA and market access for medical technologies in Europe.
12
Feb 2024

MTRC released a White Paper with a summary of clinical evidence requirements for the LPPR process for implants and invasive devices in France

In a new White Paper, MTRC identified evidence requirements for national add-on reimbursement via the LPPR List process based on analysis of five recent HAS reports with positive recommendations. Cases included technologies with different levels of added clinical value (II, III, IV, and V). A review of five cases is followed by recommendations in relation to evidence generation for medical technologies in France, and factors influencing the decision-making of HAS. The analysis was performed in February 2024.
29
Jan 2024

MTRC expanded short overviews of reimbursement systems in the Knowledge Zone domain to 31 EU countries

MTRC maintains a page with free, brief summaries of the market access landscape for medical technologies and in-vitro diagnostic tests in European countries, the Knowledge Zone. The intention of the Knowledge Zone is to become an easily accessible reference material to our clients about payment systems for medical technologies in Europe. The current version of the Knowledge Zone includes information about 30 countries: Austria, Belgium, Bulgaria, Croatia, the Czech Republic, Denmark, England, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxemburg, the Netherlands, Norway, Poland, Portugal, Romania, Scotland, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and Wales. For each country, information is provided about key market access challenges, payment mechanisms, funding and HTA barriers, and specifics of reimbursement of in-vitro diagnostic (IVD) tests.
25
Jan 2024

MTRC released a White Paper assessing evidence requirements of the NICE's early value assessment (EVA) program in the UK

Health technology assessment plays an important role in market access for medical technologies in England. NICE's early value assessment (EVA) program in medical technology, launched in 2022, assesses mostly digital technologies at an early stage in evidence generation. The program recommends the most promising technologies for use in the NHS while further evidence is being generated. NICE focuses on clinical effectiveness, safety, cost, and cost-effectiveness of the technologies. In this White Paper, MTRC performed a review of five recent EVA assessments by NICE to present the evidence requirements for digital and diagnostic medical technologies in this particular HTA program. A review of five cases is followed by recommendations in relation to evidence generation for medical technologies, market access in England, and factors influencing the decision-making of NICE.
25
Jan 2024

MTRC released a White Paper on the topic of the evidence gap analysis for medical technologies

Medical technologies face several market access challenges in Europe, including reimbursement, funding (post-reimbursement approval by payers), and health technology assessment. To overcome some of these challenges, Med Tech companies need to develop clinical and economic evidence to support the value claims about medical technologies. MTRC helps medical technology companies reduce uncertainty about evidence requirements of key European reimbursement, funding, and HTA authorities and develop a clear plan to address key gaps with clinical and economic evidence. A White Paper "Evidence Gap Analysis for Medical Technologies in Europe – a Practical Example" presents the methodological approach or MTRC and a practical example of evidence gap analysis.
15
Jan 2024

New service from MTRC – Evidence Gap Analysis

MTRC announces the start of the new service – evidence gap analysis for medical technologies in Europe. The service helps to establish the sufficiency of existing evidence to obtain reimbursement and endorsement by HTA organizations in Europe and offers recommendations for the generation of missing evidence. MTRC offers a fact-based, unbiased approach to determining clinical and economic evidence requirements, based on the benchmarking to the prevision reimbursement decisions of reimbursement authorities and HTA organizations. Recommendations are also based on an in-depth understanding of the reimbursement pathways in individual markets. Learn more on the dedicated page for this service.
14
Dec 2023

MTRC launched a service of digital health economic models

Market access eventually comes down to the hospital or individual payer level. Interactive digital tools are the essential instrument to present the value of medical technologies. MTRC launched a service of digital health economic models to present the clinical and economic value of medical technologies to hospital administrators and payers. MTRC combines an unparalleled knowledge of market access realities, drivers and barriers to the adoption of medical technologies, costing for healthcare services in 34 European countries, health economic technical expertise, and the capacity to develop nice-looking digital presentation tools at a moderate cost. See a live demo of the digital model on the website.